August 15, 2023
The 2023 Academic Ranking of World Universities (ARWU) has recognized UC San Diego as No. 4 among public universities in the United States, rising one spot from last year.
August 29, 2023
A $5 million gift from the Nancy and Geoffrey Stack Foundation has established the UC San Diego Gene Therapy Initiative to find novel therapies for children and adults with genetic diseases.
June 13, 2022
UC San Diego researchers describe connection between pediatric liver disease and increased risk of developing type 2 diabetes. Both rates are rising in children.
October 15, 2015
…a new molecule involved in skin fibrosis, a life-threatening disease characterized by the inflammation and hardening of skin tissue. The new study is the first to investigate the role of this molecule in skin fibrosis and paves the way toward new and improved therapies for the disease.
May 1, 2023
UC San Diego is a hub for rare disease research. Although each rare disease impacts a small number of people, the research findings sometimes apply to more prevalent conditions.
April 30, 2020
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
September 17, 2020
…the Division of Infectious Diseases and Global Public Health at University of California San Diego School of Medicine. “A lot of people, including myself and colleagues at UC San Diego, are working very hard to develop one or more vaccines proven safe and effective. But that goal is months away.…
November 24, 2014
…and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk…
August 20, 2020
…UC San Diego infectious disease researchers are striving to understand the complexities of living with HIV and acquiring COVID-19 Every day, she donned a mask and was vigilant about washing her hands or using hand sanitizer which made the ensuing fever, headaches, sore throat and COVID-19 diagnosis startling. Anna (a…
October 25, 2017
Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mouse model of Friedreich’s ataxia (FA) measurably halted cellular damage caused by the degenerative disease.
